Bringing the fundamentals into focus…
Back to Genmab A/S
How Genmab A/S stacks up
GMAB · against 77 other Healthcare companies of similar size
Valuation
51/ 100
Below the middle of the pack.
Ranked #49 of 78 · scores higher than 35% of peers
Bars: peers in each 10-point band of the valuation score20 peers with a valuation score of 50–59, including GMAB · Click a bar to see the companies
Why valuation scores 51?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- EBITDA yield is close to the peer norm. EBITDA yield: 3.7% vs peer median 4.0%
- Earnings yield is close to the peer norm. Earnings yield: 2.3% vs peer median 1.5%
- more free cash flow for the price paid: stronger than 64% of peers. Free cash flow yield: 2.5% vs peer median 0.0%
Metric by metric
Position: dot = GMAB, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | GMAB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 74 reported | 2.3% | 2.9% | 37% | 30% | |
| EBITDA yieldHigher is better · 79 reported | 3.7% | 5.3% | 27% | 50% | |
| Free cash flow yieldHigher is better · 53 reported | 2.5% | 3.9% | 23% | 20% | |
| Book yieldHigher is better · 73 reported | 18.0% | 20.1% | 43% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around GMAB| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.5B USD | 95 | 60 | |
| 2 | 4.61T JPY (≈$31.3B) | 93 | 76 | |
| 3 | 2.57T JPY (≈$17.5B) | 88 | 62 | |
| 4 | 6.17T JPY (≈$42.0B) | 86 | 70 | |
| 5 | 45.9B USD | 84 | 61 | |
| 45 | 16.1B CHF (≈$18.5B) | 54 | 54 | |
| 45 | 272.9B BRL (≈$49.1B) | 54 | 43 | |
| 47 | 49.5B USD | 53 | 53 | |
| 48 | 21.7B USD | 52 | 32 | |
| 49 | 34.6B USD | 51 | 58 | |
| 49 | 18.5B USD | 51 | 62 | |
| 49 | 34.0B USD | 51 | 49 | |
| 52 | 67.60T KRW (≈$48.7B) | 50 | 72 | |
| 52 | 36.0B USD | 50 | 46 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score